Back

RT @ACCinTouch
The goal of the CLEAR Outcomes trial was to compare the safety and efficacy of bempedoic acid compared with placebo among patients with or at high risk for CVD and were intolerant of statin therapy. Read more: https://bit.ly/3mDNf20 #ACC23/#WCCardio